The UAMS Myeloma Institute for Research and Therapy is the largest, most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care throughout the world, and continually translates advances in the laboratory into breakthrough clinical treatments.
Founded in 1989 by Dr. Bart Barlogie, the Myeloma Institute has seen more than 11,000 patients from every state in the United States and more than 50 foreign countries (click here for map) and has performed more than 9,000 peripheral blood stem cell transplants. Dr. Barlogie and his colleagues have fundamentally changed the course of the disease through novel diagnostic procedures and therapeutic interventions. The quality of our innovative clinical and basic science research is known around the world.
The hallmark of the Myeloma Institute is a program of well-designed clinical trials that challenge the traditional body of thought on disease treatment in order to improve outcomes. Our long-term follow-up on patients provides the large amount of statistically valid data critical for developing curative therapies.
The Myeloma Institute routinely offers Gene Array Analysis for newly referred patients and utilizes this information for patient management and planning of therapy.
The Myeloma Institute includes a focus on the prevention and management of potential treatment-related consequences, such as myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML).
The Myeloma Institute was the first to:
The Myeloma Institute is a Chancellor’s Center of Excellence at the University of Arkansas for Medical Sciences (UAMS). The UAMS Campus includes a 350-bed teaching hospital; the Jackson T. Stephens Spine & Neurosciences Institute; the Winthrop P. Rockefeller Cancer Institute; the Harvey and Bernice Jones Eye Institute; the Outpatient Center; and the Donald W. Reynolds Center on Aging. UAMS physicians are faculty members of the University’s College of Medicine.
The Myeloma Institute is housed in the Winthrop P. Rockefeller Cancer Institute.
A separate 30-bed unit in an inpatient tower built in 2008 is dedicated to the multiple myeloma/stem cell transplant service. Spacious rooms include large picture windows and comfortable seating for family members and caregivers. Specially trained Nursing and support staff are specially trained to meet the individual needs of each patient.
The Myeloma Institute clinic and administrative offices are located on the 8th floor of the Winthrop P. Rockefeller Cancer Institute (Cancer Institute). The outpatient infusion center is located on the 4th floor of the Cancer Institute.
Wireless internet access is available throughout the inpatient unit and the Cancer Institute.
Laboratory and diagnostic services are located throughout the UAMS campus. Transportation through the interior of the buildings is available for those who require assistance.
The Myeloma Institute for Research and Therapy, evolving from the breakthrough advances of the UAMS Myeloma program, is committed to accelerating curative therapies for Multiple Myeloma and related disease entities through innovative clinical and basic sciences research and outstanding patient care.
Meet the Myeloma Institute Advisory Board members.